Search Here

The world has battled cancer for many years. Whereas chemotherapy served as a crucial treatment for many cases, health experts still pushed for more and less tedious approaches. It looks like there is new hope in the fight against cancer. According to recent reports, a breakthrough in immune system treatment may offer treatment or cure to cancer.

According to a report by Eyewitness News, doctors are now addressing cervical cancer successfully through an immune system boost. By strengthening the immune system of the person, the body targets the disease. The report also noted that two successful cases have already been recorded under the treatment.

While the study can still be considered small, it does present some interesting information on how to fight cancer. One of the patients included in the study only had one year to live. However, following the conclusion of the research, the patient is one of the two reported cases treated successfully. According to reports, the two women show no signs of cancer following the new immune system treatment.

The new method is dubbed immunotherapy. It uses the body's immune cells to battle cancer in the body. For the first time, the treatment showed positive results when used to treat cervical cancer. In the mentioned study, the researchers extracted tumor samples from nine patients suffering from advanced cervical cancer. T-cells, a type of immune cells, were also extracted during the study.

The T-cells were replicated and injected back to the samples. One of the patients showed shrunken tumor whereas two of them became cancer-free.

"We can't call it a cure yet. We need time, but complete remission means complete disappearance of the tumor," explained Dr. Michael Sadelain. Dr. Sadelain works as the director of cell engineering at Memorial Sloan Kettering Cancer Center. He has more around 20 years of experience in immunotherapy. The doctor also noted that the cause of the cancer may also be helpful during the treatment.

"In cervical cancer there's a virus involved called HPV and this virus provides very good targets for the T cells to target and recognize," he said.